(Q50088416)

24 February 2018

title

Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. (English)

1 reference

24 February 2018

author name string

Judith A Siuciak

1

1 reference

24 February 2018

Douglas S Chapin

2

1 reference

24 February 2018

Sheryl A McCarthy

3

1 reference

24 February 2018

Ashley N Martin

4

1 reference

24 February 2018

publication date

2 March 2007

1 reference

24 February 2018

number of pages

10

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

24 February 2018

volume

192

1 reference

24 February 2018

issue

3

1 reference

24 February 2018

page(s)

415-424

1 reference

24 February 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0727-X

Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB1) and PDE-4 (rPDE-IVB2) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0727-X

Identification, characterization and regional distribution in brain of RPDE-6 (RNPDE4A5), a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0727-X

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-007-0727-X

The phencyclidine-glutamate model of schizophrenia.

21 January 2018

1 reference

12 December 2020

An investigation into the effect of the type IV phosphodiesterase inhibitor rolipram in the modulation of glutamate release from rat prefrontocortical nerve terminals

1 reference

12 December 2020

Schizophrenia and glutamatergic transmission

1 reference

12 December 2020

Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences

1 reference

12 December 2020

Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells

1 reference

12 December 2020

PDE4 cAMP-specific phosphodiesterases

1 reference

12 December 2020

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

12 December 2020

The up-and-down method for the determination of nociceptive thresholds in rats

1 reference

12 December 2020

Neurobiology of schizophrenia

1 reference

12 December 2020

The NMDA antagonist model for schizophrenia: promise and pitfalls.

1 reference

12 December 2020

Schizophrenia: from dopamine to glutamate and back

1 reference

12 December 2020

Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum

1 reference

12 December 2020

Rolipram attenuates MK-801-induced deficits in latent inhibition

1 reference

12 December 2020

Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis.

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Keynote review: phosphodiesterase-4 as a therapeutic target

1 reference

12 December 2020

Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A

1 reference

12 December 2020

Selective phosphodiesterase (PDE)-4 inhibitors: a novel approach to treating memory deficit?

1 reference

12 December 2020

Phosphodiesterase-4 as a potential drug target

1 reference

12 December 2020

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling

1 reference

12 December 2020

Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation

1 reference

12 December 2020

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

12 December 2020

Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications.

1 reference

12 December 2020

Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice

1 reference

12 December 2020

Characterization of the rolipram-sensitive, cyclic AMP-specific phosphodiesterases: identification and differential expression of immunologically distinct forms in the rat brain

1 reference

12 December 2020

PCP: from pharmacology to modelling schizophrenia

1 reference

12 December 2020

Deletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis

1 reference

12 December 2020

Generation of PDE4 knockout mice by gene targeting.

1 reference

12 December 2020

Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect

1 reference

12 December 2020

Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.

1 reference

12 December 2020

Biotransformation of the antidepressant D,L-rolipram. II. Metabolite patterns in man, rat, rabbit, rhesus and cynomolgus monkey.

1 reference

12 December 2020

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain

1 reference

12 December 2020

1 reference

12 December 2020

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

1 reference

12 December 2020

Immunohistochemical localization of PDE10A in the rat brain

1 reference

12 December 2020

Serotonergic involvement with neuroleptic catalepsy

1 reference

12 December 2020

Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors

1 reference

12 December 2020

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

12 December 2020

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

12 December 2020

Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling.

1 reference

12 December 2020

Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice

1 reference

12 December 2020

Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram

1 reference

12 December 2020

Improving memory: a role for phosphodiesterases

1 reference

12 December 2020

Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo

1 reference

12 December 2020

Schizophrenia: from phenomenology to neurobiology

1 reference

12 December 2020

Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: evidence for altered striatal function.

1 reference

12 December 2020

A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture

1 reference

12 December 2020

10.1007/S00213-007-0727-X

Identifiers

DOI

1 reference

24 February 2018

1 reference

24 February 2018